1-3 of 3
Mhairi Copland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3426: A synthetic lethality approach to eradicate AML via synergistic activation of pro-apoptotic p53 by MDM2 and BET inhibitors

Sha Li, Anne Latif, Ashley Newcombe, Kathryn Gilroy, Neil Robertson, Xue Lei, Darren Finlay, Helen Stewart, Karina Barbosa, Brian Higgins, Tim Chevassut, Xu Huang, Mhairi Copland, Karen Keeshan, Ani Deshpande, Peter Adams
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3426.
https://doi.org/10.1158/1538-7445.AM2020-3426
Published: 15 August 2020
View article titled, Abstract 3426: A synthetic lethality approach to eradicate AML via synergistic activation of pro-apoptotic p53 by MDM2 and BET inhibitors
Journal Articles

Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications

Peter Valent, Dominique Bonnet, Stefan Wöhrer, Michael Andreeff, Mhairi Copland, Christine Chomienne, Connie Eaves
Journal: Cancer Research
Cancer Res (2013) 73 (3): 1037–1045.
https://doi.org/10.1158/0008-5472.CAN-12-3678
Published: 31 January 2013
View article titled, Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications
Open the PDF for Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications in another window
Journal Articles

Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells

Heiko Konig, Mhairi Copland, Su Chu, Richard Jove, Tessa L. Holyoake, Ravi Bhatia
Journal: Cancer Research
Cancer Res (2008) 68 (23): 9624–9633.
https://doi.org/10.1158/0008-5472.CAN-08-1131
Published: 01 December 2008
View article titled, Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells
Open the PDF for Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells in another window
Includes: Supplementary data